<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background/Aims: MicroRNAs (miRNAs) play key roles in <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumor metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to determine the regulation and function of miR-30a in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Methods: The expression of miR-30a was detected in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines and samples by qRT-PCR </plain></SENT>
<SENT sid="3" pm="."><plain>The anti-metastatic effect of miR-30a was determined by both in vitro and in vivo assays </plain></SENT>
<SENT sid="4" pm="."><plain>A luciferase reporter assay was performed to determine target association between miR-30a and <z:chebi fb="0" ids="16749">phosphoinositide</z:chebi> 3-kinase catalytic subunit delta (PIK3CD) </plain></SENT>
<SENT sid="5" pm="."><plain>Results: miR-30a was significantly downregulated in highly metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines and metastatic tissues </plain></SENT>
<SENT sid="6" pm="."><plain>Overexpression of miR-30a suppressed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell migration and invasion in vitro and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> in vivo, whereas miR-30a deletion dramatically promoted cell migration and invasion </plain></SENT>
<SENT sid="7" pm="."><plain>Further studies revealed that PIK3CD is a direct target of miR-30a as miR-30a bounds directly to the 3'-UTR of PIK3CD, subsequently reducing its expression </plain></SENT>
<SENT sid="8" pm="."><plain>Similar to the restoring miR-30a expression, PIK3CD downregulation inhibited cell migration and invasion, whereas PIK3CD overexpression rescued the suppressive effect of miR-30a </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, significant downregulation of miR-30a in metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues was found to be inversely correlated with PIK3CD expression </plain></SENT>
<SENT sid="10" pm="."><plain>Mechanistic studies revealed that miR-30a down-regulated the expression of key components of the Akt/mTOR pathway, whereas PIK3CD overexpression reversed this negative effect </plain></SENT>
<SENT sid="11" pm="."><plain>Conclusion: Our findings indicate that miR-30a might function as a <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> suppressor in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>miR-30a may be a potential therapeutic target to block <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
</text></document>